PCA3 and Familial prostate cancer: Donovan MJ and colleagues, including Sanda MG, demonstrated that identifying exosomal PCA3 in urine and assessing T2:ERG expression levels in urine can aid in the early detection of prostate cancer, as well as monitoring disease progression and recurrence [19–21].